Explainer: RSV may not quite have the name recognition that influenza and Covid do, but it's actually causing more winter illness. New Zealand has some of the world's highest rates of serious illness ...

Local areas must have a ‘robust, clinically led and deliverable’ winter plan including vaccination uptake, NHS England (NHSE) ...

(OTC: NDTP), through its wholly owned subsidiary Good Salt Life, Inc., today announced a major expansion of the EPA-approved label for its flagship product, (EPA Reg. No. 96503-1-103745). The same ...

Older adults who received a single dose of the recombinant shingles vaccine known as Shingrix had a 24% lower chance of being ...

Every American aged 75 or older should receive a single dose of RSV vaccine ahead of the 2024-2025 respiratory season, according to a recommendation the CDC adopted after its advisory panel voted on ...

Instead, the seemingly botched experiment helped launch a new generation of therapies for autoimmune diseases afflicting hundreds of millions of people. Scientists now know that FcRn plays a crucial ...

Thank you for signing up! Did you know you can manage your profile, and explore all of the available newsletters from Louth ...

French babies who received nirsevimab had lower rates of invasive pneumococcal disease ...

RSV, short for respiratory syncytial virus, is a common respiratory infection that causes mild, cold-like symptoms in most people. While the virus usually clears up in about a ...

Health officials on Wednesday revealed there had already been 83,000 cases of respiratory syncytial virus (RSV) recorded across the country this year, outnumbering both influenza and Covid-19. More ...

The FDA approved an autoinjector form of the diuretic furosemide (Furoscix ReadyFlow) that can deliver IV-equivalent therapy ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...